Novartis (NVS) Misses Q3 EPS by 5c; Boosts FY13 Outlook

October 22, 2013 8:23 AM

Novartis (NYSE: NVS) reported Q3 EPS of $1.26, $0.05 worse than the analyst estimate of $1.31. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found